Adverse cutaneous effects of neratinib
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2018.1536253
Abstract: Abstract Neratinib is a tyrosine kinase inhibitor that was FDA-approved for extended adjuvant treatment in adults with human epidermal growth factor receptors-2 (HER-2) positive breast cancer in 2017. Due to the novelty of the drug,… read more here.
Keywords: effects neratinib; dermatology; adverse cutaneous; acneiform ... See more keywords